Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  7. 2018
2018 N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.BMC Cardiovascular Disorders.  18:66. 2018
2017 Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users.Pharmacogenetics -London-.  27:347-355. 2017
2017 Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.Circulation: Cardiovascular Quality and Outcomes.  10. 2017
2017 Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population.BMC Cardiovascular Disorders.  17:249. 2017
2017 Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.Journal of Clinical Lipidology.  11:1201-1211. 2017
2017 Design and interpretation of non-inferiority studies: A clinician's perspective.Journal of Nuclear Cardiology.  24:1994-1997. 2017
2017 Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.JAMA Cardiology.  2:890-895. 2017
2017 Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011┬áto 2014.Journal of the American College of Cardiology.  69:2696-2706. 2017
2017 Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.International Journal of Cardiology.  236:462-465. 2017
2017 Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  6. 2017
2017 Comparison of Expert Adjudicated Coronary Heart Disease and Cardiovascular Disease Mortality With the National Death Index: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  6. 2017
2017 Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.Journal of Cardiovascular Electrophysiology.  28:552-558. 2017
2017 Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibition in patients with or at high risk of coronary heart diseaseUS Cardiology.  11:16-17. 2017
2016 Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).American Heart Journal.  181:43-51. 2016
2016 Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.Heart Rhythm.  14:65-71. 2016
2016 Comparison of Length of Stay, 30-Day Mortality, and 30-Day Readmission Rates in Medicare Patients With Heart Failure and With Reduced Versus Preserved Ejection Fraction.American Journal of Cardiology.  118:79-85. 2016
2016 Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.American Journal of Cardiology.  118:232-236. 2016
2016 Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  36:263-272. 2016
2016 Response to Letter Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".Circulation.  133:e416. 2016
2015 Power and sample size in clinical studies.Journal of Nuclear Cardiology.  22:1314-1315. 2015
2015 Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.Circulation.  132:804-814. 2015
2015 Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009.American Heart Journal.  170:249-255. 2015
2015 Race influences warfarin dose changes associated with genetic factors.Blood.  126:539-545. 2015
2015 Characteristics and prognosis of acute myocardial infarction by discharge diagnosis: the Reasons for Geographic and Racial Differences in Stroke study.Annals of Epidemiology.  25:499-504.e1. 2015
2015 Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke study.American Journal of Preventive Medicine.  48:520-527. 2015
2015 Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction.Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  4. 2015
2015 Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.Journal of the American College of Cardiology.  65:270-277. 2015
2014 Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes.Annals of Epidemiology.  24:581-587. 2014
2014 Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.Diabetes Care.  37:2284-2290. 2014
2014 Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study).American Journal of Cardiology.  113:1933-1940. 2014
2014 Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  34:545-554. 2014
2014 Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).Journal of the American College of Cardiology.  63:1626-1633. 2014
2014 Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study.BMC Health Services Research.  14:195. 2014
2014 Aspirin as Primary Prevention of Acute Coronary Heart Disease Events.British Journal of Medicine and Medical Research.  4:5357-5367. 2014
2013 Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.Diabetes Care.  36:2734-2740. 2013
2013 Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.American Journal of Cardiology.  112:664-670. 2013
2013 Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study.BMC Health Services Research.  13:162. 2013
2013 Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.Vascular Health and Risk Management.  9:47-55. 2013
2012 Association of race and sex with risk of incident acute coronary heart disease events.Journal of the American Medical Association.  308:1768-1774. 2012
2012 Awareness and management of chronic disease, insurance status, and health professional shortage areas in the REasons for Geographic And Racial Differences in Stroke (REGARDS): a cross-sectional study.BMC Health Services Research.  12:208. 2012
2012 Nonalcoholic fatty liver disease and cardiovascular disease risk.Clinical Gastroenterology and Hepatology.  10:568-569. 2012
2012 Awareness, treatment and control of hypertension, diabetes and hyperlipidemia and area-level mortality regions in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.Journal of Health Care for the Poor and Underserved.  23:903-921. 2012
2012 Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.Current Hypertension Reports.  14:152-159. 2012
2012 Use of secondary prevention medications among adults with reduced kidney function.Clinical Journal of the American Society of Nephrology.  7:604-611. 2012
2012 The role of cardiac rehabilitation in heart failure patientsUS Cardiology.  9:61-65. 2012
2011 Cardiac rehabilitation outcomes: impact of comorbidities and age.Journal of Cardiopulmonary Rehabilitation.  31:342-348. 2011
2011 Health Professional Shortage Areas, insurance status, and cardiovascular disease prevention in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.Journal of Health Care for the Poor and Underserved.  22:1179-1189. 2011
2011 Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study).American Journal of Cardiology.  108:227-232. 2011
2011 Heart disease and stroke statistics--2011 update: a report from the American Heart Association.Circulation.  123:e18-e209. 2011
2011 Clinical Research in Cardiac Rehabilitation and Secondary PreventionJournal of Cardiopulmonary Rehabilitation.  31:333-341. 2011
2010 Exercise as a treatment for the risk of cardiovascular disease.Current Treatment Options in Cardiovascular Medicine.  12:329-341. 2010
2010 Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.American Heart Journal.  159:385-391. 2010
2010 Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.Circulation.  121:948-954. 2010
2010 Heart disease and stroke statistics--2010 update: a report from the American Heart Association.Circulation.  121:e46-e215. 2010
2009 Biomarkers of atherosclerosis: Clinical applicationsCurrent Cardiovascular Risk Reports.  3:23-30. 2009
2009 Assessing patient recall of discharge instructions for acute myocardial infarction.Journal for Healthcare Quality.  31:25-33. 2009
2009 Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program.Journal of the American College of Cardiology.  54:515-521. 2009
2009 Drugs are not enough: the metabolic syndrome--a call for intensive therapeutic lifestyle change.Journal of the CardioMetabolic Syndrome.  4:20-25. 2009
2008 Biomarkers of atherosclerosis: clinical applications.Current Cardiology Reports.  10:497-504. 2008
2008 Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Journal of Women's Health.  17:841-847. 2008
2007 Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.Journal of Clinical Lipidology.  1:564-574. 2007
2006 B-type natriuretic peptide level in a patient with constrictive pericarditisCatheterization and Cardiovascular Interventions.  68:832-834. 2006
2006 Quantification of tricuspid regurgitation by live three-dimensional transthoracic echocardiographic measurements of vena contracta area.Echocardiography.  23:793-800. 2006
2005 Acute Hepatitis E Infection in a Visitor to LouisianaSouthern Medical Journal.  98:721-722. 2005

Principal Investigator On

  • Private Grant  awarded by OMTHERA PHARMACEUTICALS 2014 - 2021
  • Investigator On

  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2015 - 2022
  • Patient Oriented Research in Personalized Antithrombotic Therapy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2016 - 2021
  • REasons for Geographic and Racial Differences in Stroke-Myocardial Infarction-3  awarded by Cornell University 2017 - 2021
  • Private Grant  awarded by AMGEN, INC. 2018 - 2019
  • Genetic and Clinical Predictors of Response to Warfarin and Novel Anticoagulants  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by AMGEN, INC. 2017 - 2018
  • Private Grant  awarded by HAMILTON HEALTH SCIENCES CORPORATION 2013 - 2018
  • Private Grant  awarded by Bayer HealthCare 2013 - 2018
  • Private Grant  awarded by AMGEN, INC. 2016 - 2018
  • Reasons for Geographic AND Racial Differences in Stroke-Myocardial Infarction-2  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2015 - 2017
  • Private Grant  awarded by AMGEN, INC. 2015 - 2016
  • Private Grant  awarded by AMGEN, INC. 2015 - 2016
  • Private Grant  awarded by AUM CARDIOVASCULAR 2013 - 2016
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2015
  • REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-2  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2011 - 2015
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2015
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by REGENERON PHARMACEUTICALS, INC. 2014
  • Deep South Resource Center for Minority Aging Research  awarded by National Institute on Aging/NIH/DHHS 2012 - 2014
  • Deep South Resource Center for Minority Aging Research - Investigator Development Core  awarded by National Institute on Aging/NIH/DHHS 2012 - 2014
  • Private Grant  awarded by AMGEN, INC. 2013 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2008 - 2013
  • Private Grant  awarded by AMGEN, INC. 2012 - 2013
  • Education And Training

    Full Name

  • Todd Brown
  • Blazerid

  • tmbrown